<DOC>
	<DOCNO>NCT00150514</DOCNO>
	<brief_summary>The objective study document objective immunological effect SLIT nasal mucosa . Better understanding immunological pathway , widely practise clinical therapy likely work , benefit overall outcome , patient friendly , therapy demonstrate effect SLIT allergic reaction , objective parameter , nasal tissue show true etiological treatment allergy .</brief_summary>
	<brief_title>Effects Sublingual Immunotherapy Grasspollen Allergy</brief_title>
	<detailed_description>Double blind placebo control evaluation immunological effect ( decrease IgE specific cell decrease Th2 mediator release , respectively increase Th1 mediator release ) SLIT nasal mucosal tissue adult human severe rhinocunjunctivitis due grass pollen allergy .</detailed_description>
	<criteria>1 . Age 18 old . 2 . Patients know general practice document clinical history grass pollen allergy moderate disease intensity retrospectively derive use symptomatic allergy medication previous grass pollen season , i.e . regular use cromoglycates nasal spray and/or eye drop , and/or regular use anti histamine tablet spray and/or limit use local act systemically administer corticosteroid . 3 . Positive ( ARTU ) grass pollen specific skin prick test ( despite negative RAST ) . 1 . Clinical history severe asthmatic symptom require inhalant therapy daily pulmonary steroid least 3 month year . 2 . Symptomatic perennial allergic rhinitis . Meaning perennial allergy allow allergen present patient ' daily life ( especially one month prior provocation ) apparent symptom perennial allergy . 3 . Other seasonal allergic rhinitis allow unless asymptomatic period provocation . 4 . The intention subject patient surgery nasal cavity course study . 5 . Previous immunotherapy . 6 . Negative ( ARTU ) grass pollen specific skin prick test ( despite positive RAST ) . 7 . Contraindications sublingual immunotherapy , i.e . : Malignancies serious disorder oral cavity History status asthmaticus anaphylactic shock Aggressively develop asthmatic symptom Serious chronic inflammation , chronic disorder associate fever , particularly bronchial tube Irreversible , secondary change reactive organ ( emphysema , bronchiectasis ) Auto immune disease immunodeficiency Concurrent therapy involve immunosuppressive Systemic collagen diseases Tuberculosis lung tuberculosis Serious psychological disorder Documented hypersensitivity glycerol Pregnancy Serious cardiovascular disease Usage b blocker</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2003</verification_date>
	<keyword>nasal biopsy grasspollen sublingual immunotherapy</keyword>
</DOC>